U.S. Pharmacist Weekly News Update
August 8, 2018

Adding Sulfonylurea to Metformin in T2D Better Than Switching Altogether

Sulfonylureas are a popular second-line treatment for type 2 diabetes, but a new study suggests caution in how the drugs are initiated. Find out why researchers recommend continuing with metformin when the new drug is added instead of switching to a sulfonylurea.


Proposed Algorithm Indicates Patients Who Benefit Most From Antidepressants
Antidepressants aren’t without downsides, so knowing which patients are most helped by them would be useful. A new report describes the development of an algorithm that does just that. Pharmacists might be interested in the characteristics of patients who are likely to get the greatest benefits from pharmaceutical treatment of their depression.

Testosterone Shows Promise in Mitigating Cachexia in Cancer
Not every cancer death is related only to progression of the disease, with about 20% of patients succumbing to cachexia. Now, a small study is showing promising results for an unexpected remedy. Find out how much testosterone supplementation helped combat severe loss of fat and skeletal muscle in a group of cancer patients.

Popular Supplements Found Ineffective Against Cardiovascular Disease
Just because some supplements are popular, that doesn’t mean they are effective. That was the conclusion of some recent studies finding no evidence that multivitamins, minerals, or omega-3 products promoted heart health and reduced the risk of cardiovascular disease. Here are the details.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App